8-K: Tempest Therapeutics Adjourns Special Meeting Again

Tempest Therapeutics has again adjourned its special meeting of stockholders, originally convened in July, to seek approval for a Certificate of Amendment to its Restated Certificate of Incorporation.

Summary

• Tempest Therapeutics, Inc. reconvened its special meeting of stockholders on September 15, 2026, which was originally convened on July 27, 2026, and adjourned multiple times.
• The primary purpose of the meeting is to approve an amendment to the company's Certificate of Incorporation to replace supermajority voting requirements and allow stockholder action by written consent.
• A quorum was present with 72.7% of outstanding shares represented, based on the May 28, 2026 record date.
• However, sufficient votes were not obtained to approve the proposal, leading to a further adjournment.
• The Special Meeting is now scheduled to reconvene on October 14, 2026, at 12:00 p.m. Eastern Time via live webcast.
• The proposal requires a 75% affirmative vote from stockholders.
• Stockholders who have already submitted proxies do not need to take further action unless they wish to revoke their proxy.

Sentiment

Score: 3

Explanation: StockSavvy.ai views this as a negative sentiment due to the repeated adjournment and the high voting threshold required for the proposal, indicating potential shareholder dissent or difficulty in achieving consensus.

Positives

• A quorum was established, with 72.7% of outstanding shares represented at the September 15, 2026 meeting.
• The company is actively engaging with stockholders to achieve the necessary vote, as evidenced by the multiple adjournments and continued solicitation efforts.

Negatives

• The company has failed to secure the required 75% supermajority vote for the proposed amendment on multiple occasions.
• The repeated adjournments suggest potential significant opposition or apathy among a portion of the shareholder base.
• The high voting threshold (75%) for the amendment is a significant hurdle.

Risks

• Failure to obtain the required 75% supermajority vote could prevent the company from amending its charter to allow for written consent and remove supermajority requirements.
• Continued inability to pass the proposal may signal ongoing governance challenges or shareholder dissatisfaction.
• The extended process could distract management and impact operational focus.

Future Outlook

The future outlook for the proposal's approval remains uncertain, contingent on securing the necessary 75% supermajority vote at the reconvened Special Meeting on October 14, 2026.

Management Comments

• The Company decided to adjourn the Special Meeting to provide stockholders with additional time to vote and to facilitate broader participation.

Industry Context

StockSavvy.ai notes that the push to eliminate supermajority voting requirements and enable action by written consent is a common trend in corporate governance, aimed at increasing management's flexibility and responsiveness to shareholder input, though it often faces resistance from long-term holders who prefer more stringent approval thresholds.

Corporate Governance

Stakeholder Impact

• Shareholders: The outcome of the vote directly impacts their ability to influence corporate decisions through written consent and affects the voting thresholds for future actions.
• Management: Approval of the amendment would provide management with greater operational flexibility.

Next Steps

• The Special Meeting will reconvene on October 14, 2026, at 12:00 p.m. Eastern Time via live webcast.
• Stockholders are urged to read the definitive proxy statement and other relevant documents filed with the SEC.
• The company, through Sodali & Co., will continue efforts to solicit votes to achieve the required quorum and approval threshold.

Key Dates

Recommendation

The filing concerns a procedural matter related to corporate governance and does not provide new financial results or strategic updates that would directly impact the company's valuation or immediate stock performance. The ongoing difficulty in passing a governance proposal suggests potential shareholder friction, warranting a 'hold' until clarity is achieved.

Keywords

Special Meeting, Stockholder Vote, Certificate of Amendment, Corporate Governance, Voting Requirements, Written Consent, Adjournment, Proxy